Technical discussion to define a vaccination strategy with the Jynneos vaccine against Mpox: Recommendation for vaccination with Jynneos vaccine for the following groups: 1) Pre-exposure vaccination: People living with HIV/AIDS: cisgender men, transvestites, and transgender women; aged 18 years or older; and with immune status identified by CD4 T lymphocyte count less than 200 cells in the past six months.

Recommendations for vaccination of the Yanomami indigenous people in the context of a public health emergency of national importance

Definition of the groups eligible to receive the bivalent vaccine booster in 2023: The priority groups will be staggered by phases to receive the vaccine according to the availability of immunizers in the country.